Toggle navigation
Publicações
Investigadores
Instituições
0
Entrar
Autenticação Federada
(Click on the image)
Autenticação local
Recuperação de Password
Register
Entrar
David Scott Miller
AuthID:
R-00K-250
Publicações
Confirmadas
Para Validar
Document Source:
All
Document Type:
All Document Types
Article (248)
Review (13)
Proceedings Paper (12)
Book Chapter (7)
Letter (5)
Note (4)
Editorial Material (3)
Correction (1)
Year Start - End:
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
-
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
Order:
Year Dsc
Year Asc
Cit. WOS Dsc
IF WOS Dsc
Cit. Scopus Dsc
IF Scopus Dsc
Title Asc
Title Dsc
Results:
10
20
30
40
50
Confirmed Publications: 293
31
TITLE:
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS:
Matthew A Powell;
Virginia L Filiaci
; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland;
Angeles A Secord
; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro;
Olga B Ioffe
;
David Scott Miller
;
PUBLISHED:
2022
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
40,
ISSUE:
9
INDEXED IN:
Scopus
CrossRef
:
35
IN MY:
ORCID
32
TITLE:
Risk factors associated with 30-day postoperative complications following contemporary vulvectomies with inguinofemoral lymphadenectomies for gynecologic cancers
Full Text
AUTHORS:
Alexandra Spirtos; Salvatore Lococo; Matthew Carlson; Jayanthi Lea;
David Scott Miller
; Jessica Lee;
PUBLISHED:
2022
,
SOURCE:
Gynecologic Oncology,
VOLUME:
164,
ISSUE:
1
INDEXED IN:
CrossRef
IN MY:
ORCID
33
TITLE:
145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)
AUTHORS:
Colombo, N; Lorusso, D; AD Santin; YM Kim; AC Herráez; Yonemori, K; Fujiwara, K; Colomba, E;
David Scott Miller
; Pignata, S; BJ Monk; EM Guerra; Kristeleit, R; Orlando, M; UA Sanli; Dutta, L; Orlowski, R; Ren, M; Makker, V;
PUBLISHED:
2021
,
SOURCE:
Endometrial cancer
INDEXED IN:
CrossRef
:
2
IN MY:
ORCID
34
TITLE:
726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
AUTHORS:
Colombo, N; Lorusso, D; Casado C Herráez; A.D Santin; Colomba, E;
David Scott Miller
; Fujiwara, K; Pignata, S; Floquet, A; B.J Monk; Banerjee, S; R.T Penson; Kristeleit, R; Fabbro, M; Orlando, M; Mackay, H; Jensen, E; Dutta, L; Orlowski, R; Makker, V;
PUBLISHED:
2021
,
SOURCE:
Annals of Oncology,
VOLUME:
32
INDEXED IN:
CrossRef
:
17
IN MY:
ORCID
35
TITLE:
A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer
Full Text
AUTHORS:
Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Alessandro Santin; Emeline Colomba;
David Scott Miller
; Keiichi Fujiwara; Sandro Pignata; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Jun Sakata; Kan Yonemori; Yong Man Kim; Eva Guerra; Ulus Sanli; Mary McCormack; Jie Huang; Alan Smith;
Stephen Keefe;
Lea Dutta;
Robert Orlowski;
Domenica Lorusso;
...More
PUBLISHED:
2021
,
SOURCE:
Gynecologic Oncology,
VOLUME:
162
INDEXED IN:
CrossRef
:
27
IN MY:
ORCID
36
TITLE:
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis
Full Text
AUTHORS:
Kimberly Levinson; Anna L Beavis;
Christopher Purdy
;
Anne F Rositch
; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally;
Saketh R Guntupalli
; Omar Ragab; Yi Chun Lee;
David Scott Miller
; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le;
Yovanni Casablanca
; Laura L Holman; Steven E Waggoner;
Amanda N Fader
;
...More
PUBLISHED:
2021
,
SOURCE:
Gynecologic Oncology,
VOLUME:
162,
ISSUE:
3
INDEXED IN:
Scopus
CrossRef
:
21
IN MY:
ORCID
37
TITLE:
Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538](S0090825821005114)(10.1016/j.ygyno.2021.06.017)
Full Text
AUTHORS:
Kimberly Levinson; Anna L Beavis;
Christopher Purdy
;
Anne F Rositch
; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally;
Saketh R Guntupalli
; Omar Ragab; Yi Chun Lee;
David Scott Miller
; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le;
Yovanni Casablanca
; Laura L Holman; Steven E Waggoner;
Amanda N Fader
;
...More
PUBLISHED:
2021
,
SOURCE:
Gynecologic Oncology,
VOLUME:
163,
ISSUE:
3
INDEXED IN:
Scopus
CrossRef
:
2
IN MY:
ORCID
38
TITLE:
Delayed time to surgery with hormonal treatment does not adversely impact outcomes in women with low-grade endometrioid endometrial cancer
Full Text
AUTHORS:
Sydney Oesch; Eugenia Kakadiaris;
David Scott Miller
; Matthew Carlson; Jessica Lee; Salvatore Lococo; Jayanthi Lea;
PUBLISHED:
2021
,
SOURCE:
Gynecologic Oncology,
VOLUME:
162
INDEXED IN:
CrossRef
IN MY:
ORCID
39
TITLE:
Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician’s choice (TPC).
AUTHORS:
Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro Santin; Emeline Colomba;
David Scott Miller
; Keiichi Fujiwara; Sandro Pignata; Sally E Baron-Hay; Isabelle Laure Ray-Coquard; Ronnie Shapira-Frommer; Yong Man Kim; Mary McCormack; Steven Bird; Vimalanand S Prabhu; Allison Martin Nguyen; Qi Zhao; Lea Dutta; Vicky Makker;
PUBLISHED:
2021
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
39,
ISSUE:
15_suppl
INDEXED IN:
CrossRef
:
9
IN MY:
ORCID
40
TITLE:
Is there a need for consultant team for bowel resection? An evaluation of surgical outcomes of bowel resection at time of ovarian cytoreductive surgery
Full Text
AUTHORS:
Terrence Wong; Matthew Carlson; Jayanthi Lea; Salvatore Lococo;
David Scott Miller
; Jessica Lee;
PUBLISHED:
2021
,
SOURCE:
Gynecologic Oncology,
VOLUME:
162
INDEXED IN:
CrossRef
IN MY:
ORCID
Adicionar à lista
Marked
Marcar Todas
Export
×
Publication Export Settings
BibTex
EndNote
APA
CSV
PDF
Export Preview
Print
×
Publication Print Settings
HTML
PDF
Print Preview
Página 4 de 30. Total de resultados: 293.
<<
<
1
2
3
4
5
6
7
8
9
>
>>
×
Select Source
This publication has:
2 records from
ISI
2 records from
SCOPUS
2 records from
DBLP
2 records from
Unpaywall
Please select which records must be used by Authenticus!
×
Preview Publications
© 2024 CRACS & Inesc TEC - All Rights Reserved
Privacy Policy
|
Terms of Service